CYP3A4-mediated hepatic metabolism of the HIV-1 protease inhibitor saquinavir in vitro

By Eaglings V. A.   Wiltshire H.   Whitcombe I. W. A.   Back D. J.  

Xenobiotica, Vol. 32, Iss. 1, 2002-01 ,pp. : 1-17

Informa Healthcare

Access to resources Recommend Favorite

In vitro metabolism, glutathione conjugation, and CYP isoform specificity of epoxidation of 4-vinylphenol

By Zhang Fagen   Lowe Ezra R.   Rick David.L.   Qiu Xiaohua   Leibold E.   Cruzan George   Bartels Michael J.  

Xenobiotica, Vol. 41, Iss. 1, 2011-01 ,pp. : 6-23

Informa Healthcare

Access to resources Recommend Favorite

In vitro model for the prediction of clinical CYP3A4 induction using HepaRG cells

By Kaneko A.   Kato M.   Sekiguchi N.   Mitsui T.   Takeda K.   Aso Y.  

Xenobiotica, Vol. 39, Iss. 11, 2009-11 ,pp. : 803-810

Informa Healthcare

Access to resources Recommend Favorite

Metabolism and clinical pharmacokinetics of 2-methyl-n-(2′-(pyrrolidinyl-1-ylsulfonyl)-n-[1,1′-biphenyl]-4-yl)propran-1-amine: insights into monoamine oxidase- and CYP-mediated disposition by integration of in vitro ADME tools

By Sawant Basak Aarti   Byon Wonkyung   Tseng-Lovering Elaine   Funk Carrie   Wood Linda   Lin Chang   Delnomdedieu Marielle   Verhoest Patrick   Parikh Vinod   Cox Loretta M.   Miller Emily   Gao Hongying   Obach Ronald S.  

Xenobiotica, Vol. 44, Iss. 5, 2014-05 ,pp. : 438-454

Informa Healthcare

Access to resources Recommend Favorite

Carbamazepine: a 'blind' assessment of CYP-associated metabolism and interactions in human liver-derived in vitro systems

By Pelkonen O.   Myllynen P.   Taavitsainen P.   Boobis A. R.   Watts P.   Lake B. G.   Price R. J.   Renwick A. B.   Gómez-Lechón M.-J.   Castell J. V.   Ingelman-Sundberg M.   Hidestrand M.   Guillouzo A.   Corcos L.   Goldfarb P. S.   Lewis D. F. V.  

Xenobiotica, Vol. 31, Iss. 6, 2001-06 ,pp. : 321-343

Informa Healthcare

Access to resources Recommend Favorite